 RALEIGH, NC ACCESSWIRE January 4, 2022 9 Meters Biopharma, Inc. NASDAQ:NMTR the Company, a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases by studying unique GI biology, today announced that the Companys CEO, John Temperato along with other management team members will participate in the following conferences in January and invites investors to participate in virtual one-on-one meetings. Please see additional details below: 11th Annual LifeSci Partners Corporate Access Event Wednesday, January 5th - Friday, January 7th Registration Link or submit 1x1 meeting requests HERE H.C. 